AstraZeneca to drop psychiatric research
AstraZeneca is to cease researching drugs for illnesses including schizophrenia and ovarian cancer in a shake-up of its research and development activities.
Wednesday, March 3, 2010
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment